Starting with February 9th, 2019, the medicine pack as we knew it, changed. The novelty elements brought by the implementation of the Falsified Medicines Directive: the Unique Identifier, encoded in the 2D Data Matrix code, and the anti-tempering device have proven of crucial importance in protecting patients’ safety. According to the Commission Delegated Regulation (EU) […]
Starting with 06.05.2022, the IQE Testing Report for the Romanian National Medicines Verification System’s End-Users has an updated version which you can find on the page: IQE Testing
Download TeleConf 28.04.22
EMVO announced the confirmation of EU Hub 1.11 deployment to the Integrated Test Environment (ITE). EMVO LoA
Please click on the link below for more details on the planned deployment dates for ITE, IQE & PRD for the EU Hub Release 1.11. EMVO LoA
Kindly be informed that during the previous 3 months OSMR has analysed a large number of incidents reported by the National Medicines Verification System (NMVS) End-Users, who encountered difficulties in installing the new digital certificates required for the authentication process for NMVS (especially on the Windows 7 operating system). OSMR has escalated to issue to […]
We are extremely honored to continue the series of Pharma Industry’s Perspectives on Serialisation by having with us Mrs. Anca Crupariu, Pharmacists Professional Organisation’s Spokesperson, who outlined the benefits of the Falsified Medicines Directive implementation: “To understand the importance of implementing the so-called Falsified Medicines Directive (Directive 2011/62/EU) we should begin with the definition of […]
In its latest communication, EMVO emphasizes the importance of updating the EU Hub certificates and endpoints as these are critical for the OBPs (and MAHs) to remain connected to the EU Hub. Please find out more about this topic by clicking the link below. EMVO LoA
[pdf-embedder url=”https://staging.osmr.ro/wp-content/uploads/2022/04/The-Efficient-Collaboration-EN.pdf” title=”Successful Collaboration_OSMR_ANMDMR”]
As it has been previously communicated, the V3 version of the National Medicines Verification System (NMVS) interface will be disconnected at the beginning of June, when the V5 version will be released. It is important to note that all End-Users who use V3 will be disconnected from the NMVS and will not be able to […]